Variable | Total (N = 132) | OA-Treated (n = 39) | OA-Untreated (n = 93) | P Value |
---|---|---|---|---|
Age, yr, No (%) | ||||
Median, Range | 63(30–88) | 62(38–81) | 64(30–88) | |
≤ 65 | 84(63.6) | 26(66.7) | 58(62.4) | 0.639 |
> 65 | 48(36.4) | 13(33.3) | 35(37.6) | |
Gender, No (%) | ||||
Female | 35(26.5) | 12(30.8) | 23(24.8) | 0.473 |
Male | 97(73.5) | 27(69.2) | 70(75.2) | |
Smoking, No (%) | ||||
No | 60(45.5) | 21(53.8) | 39(41.9) | 0.210 |
Yes | 78(54.5) | 18(46.2) | 54(58.1) | |
ECOG PS, No (%) | ||||
0 | 55(41.7) | 20(51.3) | 35(37.6) | |
1 | 22(16.7) | 6(15.4) | 16(17.2) | 0.293 |
2 | 47(35.6) | 10(25.6) | 37(39.8) | |
3 | 8(6.0) | 3(7.7) | 5(5.4) | |
Histology, No (%) | ||||
Squamous | 54(40.9) | 16(41.0) | 38(40.9) | 0.208 |
Adenocarcinoma | 49(37.1) | 11(28.2) | 38(40.9) | |
Small cell | 29(22.0) | 12(30.8) | 17(18.2) | |
Neoplasm staging, No (%) | ||||
III | 9(6..8) | 2(5.1) | 7(7.5) | 0.285 |
IV | 106(80.3) | 33(84.7) | 73(78.5) | |
Recurrent | 17(12.9) | 4(10.2) | 13(14.0) | |
Family History, No (%) | ||||
Yes | 20(15.2) | 8(20.5) | 12(12.9) | 0.266 |
No | 112(84.8) | 31(79.5) | 81(87.1) | |
No..of treatment line. No (%) | ||||
1 | 40(30.3) | 7(17.9) | 33(35.5) | 0.293 |
2 | 77(58.3) | 28(71.8) | 49(52.7) | |
3 | 12(9.1) | 3(7.7) | 9(9.7) | |
4 | 3(2.3) | 1(2.6) | 2(2.2) | |
Recurrence after operation, No (%) | ||||
Yes | 17(12.9) | 4(10.3) | 13(14.0) | 0.560 |
No | 115(87.1) | 35(89.7) | 80(86.0) | |
Treatment regimen, No (%) | ||||
ICIs monotherapy | 26(19.7) | 10(25.6) | 16(17.2) | 0.545 |
ICIs + chemo | 91(68.9) | 26(66.7) | 65(69.9) | |
ICIs + anti-EGFR | 2(1.5) | 0(0.00) | 2(2.2) | |
ICIs + anti-angiogenesis | 13(9.8) | 3(7.7) | 10(20.8) |